Aspira Women’s Health (NYSE:AWH) Receives New Coverage from Analysts at

Aspira Women's Health Inc. began coverage on shares of Aspira Women’s Health (NYSE:AWH – Get Rating) in a research report report published on Tuesday. The firm issued a sell rating on the stock.

Aspira Women’s Health Stock Up 1.3 %

AWH opened at $3.02 on Tuesday. Aspira Women’s Health has a one year low of $2.65 and a one year high of $16.50.

Aspira Women’s Health (NYSE:AWH – Get Rating) last issued its quarterly earnings data on Wednesday, March 22nd. The company reported ($0.60) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.90) by $0.30. The company had revenue of $2.15 million during the quarter, compared to analysts’ expectations of $2.40 million.

About Aspira Women’s Health

Want More Great Investment Ideas?

(Get Rating)

Aspira Women’s Health Inc., together with its subsidiaries, is engaged in developing and commercializing diagnostic tests for gynecologic diseases in the United States. The company’s products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.

Read More

Receive News & Ratings for Aspira Women’s Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aspira Women’s Health and related companies with’s FREE daily email newsletter.

Similar Posts